Valuation: Medtronic plc

Capitalization 109B 92.61B 84.88B 80.61B 149B 10,150B 152B 996B 392B 4,897B 409B 401B 17,305B P/E ratio 2026 *
21x
P/E ratio 2027 * 18.2x
Enterprise value 133B 113B 103B 98.19B 181B 12,364B 185B 1,213B 477B 5,965B 499B 488B 21,080B EV / Sales 2026 *
3.68x
EV / Sales 2027 * 3.43x
Free-Float
99.72%
Yield 2026 *
3.36%
Yield 2027 * 3.56%
1 day-1.38%
1 week-3.41%
Current month-1.90%
1 month-1.35%
3 months-13.79%
6 months-11.38%
Current year-11.51%
1 week 84.99
Extreme 84.99
87.9
1 month 84.92
Extreme 84.92
89.18
Current year 84.92
Extreme 84.92
105.5
1 year 79.93
Extreme 79.93
106.33
3 years 68.84
Extreme 68.84
106.33
5 years 68.84
Extreme 68.84
135.89
10 years 68.84
Extreme 68.84
135.89
Manager TitleAgeSince
Chief Executive Officer 56 26/04/2020
Director of Finance/CFO 56 02/03/2025
Chief Tech/Sci/R&D Officer 55 31/08/2020
Director TitleAgeSince
Director/Board Member 66 25/01/2015
Director/Board Member 64 31/12/2012
Director/Board Member 70 31/12/2014
Change 5d. change 1-year change 3-years change Capi.($)
-1.38%-3.41%+2.91%+1.81% 111B
-0.84%-4.66%-26.71%-13.00% 169B
-1.39%+1.22%+12.65%+94.63% 63.72B
-0.46%+0.37%+89.11%+112.46% 61.53B
+0.06%+2.07%-20.17%-39.43% 45.14B
+1.30%+2.20% - - 38.67B
+1.00%+2.38%-5.76%-47.12% 24.69B
+0.27%+0.69%+1.88%+22.09% 22.14B
-1.06%+7.36%-0.24%-26.55% 21.67B
-2.31%-0.05%-20.26%+9.03% 20.29B
Average -0.36%+0.87%+3.71%+12.66% 57.71B
Weighted average by Cap. -0.33%-1.19%+1.26%+15.06%

Financials

2026 *2027 *
Net sales 36.12B 30.65B 28.09B 26.68B 49.3B 3,359B 50.36B 330B 130B 1,621B 135B 133B 5,727B 38.23B 32.45B 29.74B 28.24B 52.19B 3,556B 53.31B 349B 137B 1,716B 143B 140B 6,063B
Net income 5.25B 4.46B 4.08B 3.88B 7.17B 488B 7.32B 47.91B 18.84B 236B 19.69B 19.29B 833B 5.86B 4.97B 4.56B 4.33B 8B 545B 8.17B 53.47B 21.03B 263B 21.98B 21.52B 929B
Net Debt 23.81B 20.2B 18.52B 17.58B 32.5B 2,214B 33.19B 217B 85.43B 1,068B 89.29B 87.44B 3,775B 22.09B 18.74B 17.18B 16.31B 30.15B 2,054B 30.79B 202B 79.26B 991B 82.84B 81.13B 3,502B
Logo Medtronic plc
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (25%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (19%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (18.1%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - cranial and spinal technologies (14.8%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.7%); - diabetes management (8.2%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.7%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ; - other (0.5%). Net sales are distributed geographically as follows: Ireland (0.3%), the United States (51.2%) and other (48.5%).
Employees
95,000
Date Price Change Volume
20/04/26 85.00 $ -1.38% 8,426,017
17/04/26 86.19 $ +0.63% 10,461,061
16/04/26 85.65 $ -1.66% 8,816,850
15/04/26 87.10 $ -1.16% 8,543,161
14/04/26 88.12 $ +0.14% 5,640,336
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
85.00USD
Average target price
109.08USD
Spread / Average Target
+28.33%

Quarterly revenue - Rate of surprise